Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock Holdings Cut by Cadinha & Co. LLC

Cadinha & Co. LLC decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1.5% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 63,953 shares of the medical equipment provider's stock after selling 990 shares during the quarter. Intuitive Surgical makes up about 6.8% of Cadinha & Co. LLC's holdings, making the stock its 3rd largest position. Cadinha & Co. LLC's holdings in Intuitive Surgical were worth $31,674,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. lifted its position in shares of Intuitive Surgical by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock valued at $16,813,478,000 after acquiring an additional 360,591 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Intuitive Surgical by 3.2% in the 4th quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider's stock valued at $4,039,200,000 after purchasing an additional 243,802 shares during the last quarter. Fisher Asset Management LLC lifted its holdings in shares of Intuitive Surgical by 1.8% during the 4th quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider's stock valued at $2,541,356,000 after acquiring an additional 86,488 shares in the last quarter. Norges Bank acquired a new position in shares of Intuitive Surgical during the 4th quarter valued at $2,401,493,000. Finally, Invesco Ltd. lifted its holdings in Intuitive Surgical by 7.7% in the 4th quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider's stock worth $2,165,184,000 after buying an additional 295,025 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Down 0.5%

Intuitive Surgical stock traded down $3.03 during midday trading on Tuesday, reaching $550.26. The stock had a trading volume of 413,663 shares, compared to its average volume of 1,639,406. The firm has a market capitalization of $197.22 billion, a PE ratio of 85.84, a P/E/G ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 12 month low of $397.47 and a 12 month high of $616.00. The firm's 50-day moving average price is $517.32 and its 200 day moving average price is $538.73.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same period in the prior year, the business earned $1.50 earnings per share. Equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Activity

In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of the stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,607,925.28. This represents a 68.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Brian Edward Miller sold 8,900 shares of the firm's stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the transaction, the executive vice president now owns 5,758 shares of the company's stock, valued at $2,793,033.06. The trade was a 60.72% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 25,778 shares of company stock valued at $12,867,197. 0.70% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

ISRG has been the subject of several research analyst reports. Citigroup reissued a "buy" rating and issued a $650.00 target price (up previously from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Truist Financial reduced their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a research note on Wednesday, April 23rd. Royal Bank of Canada cut their price target on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the company a "buy" rating in a research note on Monday, April 14th. Finally, Evercore ISI dropped their price target on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a research note on Wednesday, April 23rd. Five investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $596.05.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.